- Forums
- ASX - By Stock
- GUE
- Why is OKR under the radar of Uranium investors?
Why is OKR under the radar of Uranium investors?, page-68
-
- There are more pages in this discussion • 102 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GUE (ASX) to my watchlist
|
|||||
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.08M |
Open | High | Low | Value | Volume |
5.4¢ | 5.4¢ | 5.3¢ | $10.65K | 200.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 45866 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 148182 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 45866 | 0.053 |
2 | 89706 | 0.052 |
3 | 120440 | 0.051 |
6 | 420000 | 0.050 |
2 | 205000 | 0.049 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 148182 | 1 |
0.055 | 17172 | 1 |
0.057 | 87719 | 1 |
0.058 | 50000 | 1 |
0.059 | 200000 | 1 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
GUE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online